Lista de obras - Axel Dignass - Dominio Público Uruguay

"Addition of granulocyte/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A randomized, multicentre, clinical trial".

artículo científico publicado en 2018

1073 Analytical Performance of a New iPhone-Based Patient Monitoring System Comparable to ELISA for Measuring Fecal Calprotectin in IBD Patients

artículo científico publicado en 2016

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management

artículo científico publicado en 2016

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations

artículo científico publicado en 2016

A Prospective Cohort Study to Assess the Relevance of Vedolizumab Drug Level Monitoring in IBD Patients

artículo científico publicado en 2017

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

artículo científico publicado en 2019

A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patients

artículo científico publicado en 2018

Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications

artículo científico publicado en 2018

An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease

artículo científico publicado en 2018

Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases

scientific article published on 19 June 2019

Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator

artículo científico publicado en 2012

Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids

artículo científico publicado en 2007

Complementary therapies in inflammatory bowel diseases

artículo científico

Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

scientific article published on 02 June 2020

Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe

artículo científico publicado en 2017

Current evaluation and management of anemia in patients with inflammatory bowel disease

artículo científico publicado en 2016

DLG5 variants in inflammatory bowel disease

artículo científico publicado en 2006

Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus.

artículo científico publicado en 2017

Digestive Diseases. Introduction

artículo científico publicado en 2014

Editorial: which iron preparation for patients with IBD? Authors' reply.

artículo científico publicado en 2017

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study

artículo científico publicado en 2016

Effects of systemic administration of a local anesthetic on pain in acute pancreatitis: a randomized clinical trial

artículo científico publicado en 2011

Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial

artículo científico publicado en 2017

European evidence based consensus on surgery for ulcerative colitis

artículo científico publicado en 2015

European evidenced-based consensus on reproduction in inflammatory bowel disease

artículo científico publicado en 2010

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

artículo científico publicado en 2016

Experience with a training program for transgastric procedures in NOTES.

artículo científico publicado en 2009

Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle

artículo científico publicado en 2008

Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis

artículo científico publicado en 2018

Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases

artículo científico publicado en 2007

Impact of pain on health-related quality of life in patients with inflammatory bowel disease

artículo científico publicado en 2010

Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitis

scientific article published on 08 February 2019

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management

artículo científico publicado en 2017

Late graft loss after intestinal transplantation in an adult patient as a result of necrotizing enterocolitis

artículo científico publicado en 2003

Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark

artículo científico publicado en 2019

Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply.

artículo científico publicado en 2017

Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions.

artículo científico publicado en 2018

Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs

artículo científico publicado en 2020

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease

artículo científico publicado en 2017

Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice.

artículo científico publicado en 2017

Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines

artículo científico

Management of severe refractory adult autoimmune enteropathy with infliximab and tacrolimus

artículo científico publicado en 2005

Mesalamine in the treatment of active Crohn's disease

artículo científico publicado en 2005

Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease

artículo científico publicado en 2020

Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis

artículo científico publicado en 2005

Overcoming the barriers to dissemination and implementation of quality measures for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology (UEG) position statement

artículo científico publicado en 2020

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis

artículo científico publicado en 2010

Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis

artículo científico publicado en 2007

Reply to Drs. Silva and Santana's letter ⬇️

artículo científico publicado el 16 de septiembre de 2012

Review article: treating-to-target for inflammatory bowel disease-associated anaemia

artículo científico publicado en 2018

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

artículo científico publicado en 2020

Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results

artículo científico publicado en 2016

Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice

scientific article published on 17 September 2018

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

artículo científico publicado en 2012

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

artículo científico

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations

artículo científico

Selective Glucocorticoid Receptor Agonists for Treatment of Inflammatory Bowel Disease – in vitro studies

artículo científico publicado en 2011

Sexual function in persons with inflammatory bowel disease: a survey with matched controls

artículo científico publicado en 2007

Su1840 The Efficacy of Intravenous Iron Therapy in IBD Patients With Active Disease Is Not Influenced by the Degree of Inflammatory Activity

artículo científico publicado en 2016

Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation

artículo científico publicado en 2003

Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease.

artículo científico publicado en 2017

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

scientific article published on 01 February 2020

The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease

artículo científico publicado en 2007

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis ⬇️

artículo científico publicado el 15 de enero de 2010

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

artículo científico publicado en 2009

Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis

artículo científico publicado en 2006

UEG Standards and Guidelines: A UEG initiative to reduce health inequalities across Europe

artículo científico publicado en 2016

Young GI angle: How to find and read guidelines?

article published in 2018

Lista de obras de Axel Dignass

"Addition of granulocyte/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A randomized, multicentre, clinical trial".

1073 Analytical Performance of a New iPhone-Based Patient Monitoring System Comparable to ELISA for Measuring Fecal Calprotectin in IBD Patients

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations

A Prospective Cohort Study to Assess the Relevance of Vedolizumab Drug Level Monitoring in IBD Patients

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patients

Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications

An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease

Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases

Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator

Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids

Complementary therapies in inflammatory bowel diseases

Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe

Current evaluation and management of anemia in patients with inflammatory bowel disease

DLG5 variants in inflammatory bowel disease

Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus.

Digestive Diseases. Introduction

Editorial: which iron preparation for patients with IBD? Authors' reply.

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study

Effects of systemic administration of a local anesthetic on pain in acute pancreatitis: a randomized clinical trial

Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial

European evidence based consensus on surgery for ulcerative colitis

European evidenced-based consensus on reproduction in inflammatory bowel disease

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

Experience with a training program for transgastric procedures in NOTES.

Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle

Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis

Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases

Impact of pain on health-related quality of life in patients with inflammatory bowel disease

Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitis

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management

Late graft loss after intestinal transplantation in an adult patient as a result of necrotizing enterocolitis

Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark

Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply.

Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions.

Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease

Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice.

Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines

Management of severe refractory adult autoimmune enteropathy with infliximab and tacrolimus

Mesalamine in the treatment of active Crohn's disease

Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease

Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis

Overcoming the barriers to dissemination and implementation of quality measures for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology (UEG) position statement

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis

Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis

Reply to Drs. Silva and Santana's letter ⬇️

Review article: treating-to-target for inflammatory bowel disease-associated anaemia

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results

Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations

Selective Glucocorticoid Receptor Agonists for Treatment of Inflammatory Bowel Disease – in vitro studies

Sexual function in persons with inflammatory bowel disease: a survey with matched controls

Su1840 The Efficacy of Intravenous Iron Therapy in IBD Patients With Active Disease Is Not Influenced by the Degree of Inflammatory Activity

Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation

Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease.

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis ⬇️

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis

UEG Standards and Guidelines: A UEG initiative to reduce health inequalities across Europe

Young GI angle: How to find and read guidelines?